IVF: induction of ovulation in poor responders.
All IVF programs have a consistent rate of failure in inducing ovulations. Pharmacological induction of ovulation is otherwise crucial for an IVF program because of the need for more than one ovum. Since it is well known that the best candidates for HMG treatment are hypogonadotropic women a short reversible hypogonadotropic state was induced in IVF patients by LH-RH agonist (Buserelin). Superovulation was then achieved with very high initial doses of FSH (Metrodin) in order to maximize the ovarian response. This technique used in 116 IVF women induced a satisfactory follicle growth even in 70% of the patients already poorly responsive to HMG stimulation.
Crosignani
P G
PG
III Department of Obstetrics and Gynecology, University of Milan, Italy.
Ragni
G
G
Lombroso
G C
GC
Scarduelli
C
C
de Lauretis
L
L
Caccamo
A
A
Dalprà
L
L
Cavioni
V
V
Cristiani
C
C
Wyssling
H
H
D000328:Adult; D002064:Buserelin / Q000627:therapeutic use; D006063:Chorionic Gonadotropin / Q000627:therapeutic use; D005260:Female; D005307:Fertilization in Vitro; D006801:Humans; D008597:Menstrual Cycle; D009640:Norethindrone / Q000627:therapeutic use; D009865:Oocytes / Q000166:cytology / Q000187:drug effects; D010062:Ovulation Induction
D006063:Chorionic Gonadotropin; D002064:Buserelin; D009640:Norethindrone